Alpa Laboratories Limited (ALPA)
ISIN: INE385I01010 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
67.9
-1.4(-2.02%)

Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.

Pricing Updates

TODAY'S HIGH

68.95

TODAY'S LOW

65.9

52 WEEK HIGH

108.8

52 WEEK LOW

46.75

Major Holders

% of Shares Held by
All Insider

59.09%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

144.11 Cr.

ETERPRISE VALUE

112.36 Cr.

NO. OF SHARES

2.10 Cr.

BOOK VALUE

57.011

DIV. YIELD

None%

DEBT

5.54 Cr.

GROSS PROFIT

32.79 Cr.

CASH

61.41 Cr.

REVENUE

112.09 Cr.

REVENUE/SHARE

53.255

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments7.90 Cr.-11.60 Cr.-11.87 Cr.-17.97 Cr.
Change To Liabilities12.72 Cr.-1.19 Cr.1.89 Cr.-11.23 Cr.
Total cashflows from Investing Activities5.86 Cr.-11.16 Cr.-14.66 Cr.-11.47 Cr.
Net Borrowings26.35 Lakhs-1.27 Cr.-4.32 Cr.9.89 Cr.
Total Cash from Financing Activities18.57 Lakhs-1.34 Cr.-4.77 Cr.8.83 Cr.
Other Liabilities-53.94 Lakhs8.54 Lakhs3.27 Cr.-16 Lakhs
Total Assets0000
Net Income7.24 Cr.1.85 Cr.1.01 Cr.2.80 Cr.
Change in Cash4.35 Cr.5.27 Cr.-20.44 Cr.-15.34 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities-1.69 Cr.17.78 Cr.-1 Cr.-12.70 Cr.
Depreciation1.22 Cr.1.14 Cr.1.09 Cr.1.04 Cr.
Other Cashflows from Investing Activities79.35 Lakhs1.61 Cr.3.85 Cr.4.28 Cr.
Dividends Paid0000
Change to Inventory-4 Cr.1.48 Cr.-31.56 Lakhs-68 Lakhs
Change to Account Receivables-18.50 Cr.9.77 Cr.-7.23 Cr.-4.27 Cr.
Other Cashflows from Financing Activities-7.78 Lakhs-7.68 Lakhs-44.92 Lakhs-1.06 Cr.
Change to Net Income15.89 Lakhs4.63 Cr.-72.51 Lakhs-21.43 Lakhs
Capital Expenditures-3.21 Cr.-2.54 Cr.-85.31 Lakhs-1.97 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax10.78 Cr.2.90 Cr.2.75 Cr.4.64 Cr.
Minority InterestNoneNoneNoneNone
Net Income7.40 Cr.4.71 Cr.24.01 Lakhs3.31 Cr.
Selling General Administrative12 Cr.12.16 Cr.12.58 Cr.10.61 Cr.
Gross Profit32.79 Cr.30.69 Cr.24.88 Cr.23.03 Cr.
Ebit7.40 Cr.4.71 Cr.24.01 Lakhs3.31 Cr.
Operating Income7.40 Cr.4.71 Cr.24.01 Lakhs3.31 Cr.
Other Operating Expenses12.16 Cr.12.67 Cr.10.96 Cr.8.04 Cr.
Interest Expense-2.61 Lakhs-9.51 Lakhs-47.68 Lakhs-78.10 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense3.53 Cr.1.05 Cr.1.74 Cr.1.83 Cr.
Total Revenue97.55 Cr.85.96 Cr.77.98 Cr.62.84 Cr.
Total Operating Expenses90.14 Cr.81.25 Cr.77.74 Cr.59.53 Cr.
Cost of Revenue64.75 Cr.55.27 Cr.53.09 Cr.39.81 Cr.
Total Other Income Expense Net3.38 Cr.-1.80 Cr.2.51 Cr.1.32 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.7.24 Cr.1.85 Cr.1.01 Cr.2.80 Cr.
Net Income Applicable to Common Shares7.24 Cr.1.85 Cr.1.01 Cr.2.80 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets5.51 Lakhs000
Capital Surplus54.96 Cr.54.96 Cr.54.96 Cr.54.96 Cr.
Total Liabilities32.72 Cr.20.97 Cr.22.72 Cr.23.97 Cr.
Stock Holder Equity107.64 Cr.100.37 Cr.98.49 Cr.97.54 Cr.
Minority Interest0000
Other Liabilities6.21 Cr.5.66 Cr.6.25 Cr.3.71 Cr.
Total Assets140.36 Cr.121.35 Cr.121.21 Cr.121.52 Cr.
Common Stock21.04 Cr.21.04 Cr.21.04 Cr.21.04 Cr.
Retained Earnings31.64 Cr.24.37 Cr.22.49 Cr.21.54 Cr.
Other Liabilities21.60 Lakhs-1 k1 k1 k
Good Will002.02 Cr.4.04 Cr.
Treasury Stock0000
Other Assets33.85 Lakhs1.37 Cr.60.13 Lakhs76.14 Lakhs
Cash1.80 Cr.4.97 Cr.14.91 Lakhs19.03 Lakhs
Current Liabilities32.50 Cr.20.78 Cr.22.31 Cr.23.36 Cr.
Long Term Asset Charges092.58 Lakhs17.10 Lakhs76.13 Lakhs
Short Long Term Debt18.29 Lakhs21.93 Lakhs20.24 Lakhs18.67 Lakhs
Other Stockholder Equity0000
Property Plant Equipment8.73 Cr.7.21 Cr.5.87 Cr.6.12 Cr.
Total Cur. Assets121.09 Cr.95.47 Cr.94.08 Cr.97.72 Cr.
Long Term Investments10.15 Cr.17.28 Cr.18.62 Cr.12.87 Cr.
Net Tangible Assets107.58 Cr.100.37 Cr.96.47 Cr.93.50 Cr.
Short Term Investments0000
Net Receivables38.12 Cr.26.57 Cr.37.73 Cr.35.76 Cr.
Long Term Debt91 k19.20 Lakhs41.13 Lakhs61.37 Lakhs
Inventory16.55 Cr.12.55 Cr.14.03 Cr.13.72 Cr.
Accounts Payable24.73 Cr.13.69 Cr.13.18 Cr.13.27 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account